Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis

Oncogene

Volumn 32, Issue 1, 2013, Pages 106-116

  Wilting, S M ^a   Snijders, P J F ^a   Verlaat, W ^a   Jaspers, A ^a   Van De Wiel, M A ^a,b   Van Wieringen, W N ^a,b   Meijer, G A ^a   Kenter, G G ^a   Yi, Y ^c   Le Sage, C ^d,e   Agami, R ^d   Meijer, C J L M ^a   Steenbergen, R D M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

adenocarcinoma; CIN lesion; HPV; hsa miR 9; microRNA; squamous cell carcinoma

Indexed keywords

MICRORNA; MICRORNA 100; MICRORNA 101; MICRORNA 107; MICRORNA 10A; MICRORNA 125B; MICRORNA 135B; MICRORNA 143; MICRORNA 145; MICRORNA 146B 5P; MICRORNA 150; MICRORNA 151 3P; MICRORNA 15B; MICRORNA 181B; MICRORNA 191; MICRORNA 192; MICRORNA 24; MICRORNA 26A; MICRORNA 26B; MICRORNA 28 5P; MICRORNA 29A; MICRORNA 29B; MICRORNA 29C; MICRORNA 30A; MICRORNA 30C; MICRORNA 331 3P; MICRORNA 34C 5P; MICRORNA 425; MICRORNA 9; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADENOCARCINOMA; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CHROMOSOME ABERRATION; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; UPREGULATION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM;

CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MICRORNAS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 84871945452     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.20     Document Type: Article

References (60)

1. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-265.
2. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.
3. Fu Y, Reagan J. Pathology of the Uterine Cervix, Vagina and Vulva. Major Problems in Pathology. W.B. Saunders and Co.: Philadelphia, 1989, pp 288-335.
4. Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002; 97: 72-81.
5. McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: A retrospective cohort study. Lancet Oncol 2008; 9: 425-434.
6. Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G et al. Typespecific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1999; 341: 1633-1638.
7. Winer RL, Kiviat NB, Hughes JP, Adam DE, Lee SK, Kuypers JM et al. Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis 2005; 191: 731-738.
8. Zielinski GD, Snijders PJ, Rozendaal L, Voorhorst FJ, van der Linden HC, Runsink AP et al. HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears. Br J Cancer 2001; 85: 398-404.
9. Li B, Hu Y, Ye F, Li Y, Lv W, Xie X. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection. Int J Gynecol Cancer 2010; 20: 597-604.
10. Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP, Khan SA. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervicalcarcinoma cells. Oncogene 2008; 27: 2575-2582.
11. McKenna DJ, McDade SS, Patel D, McCance DJ. MicroRNA 203 expression in keratinocytes is dependent on regulation of p53 levels by E6. J Virol 2010; 84: 10644-10652.
12. Melar-New M, Laimins LA. Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins. J Virol 2010; 84: 5212-5221.
13. Nuovo GJ, Wu X, Volinia S, Yan F, di LG, Chin N et al. Strong inverse correlation between microRNA-125b and human papillomavirus DNA in productive infection. Diagn Mol Pathol 2010; 19: 135-143.
14. Wang X, Wang HK, McCoy JP, Banerjee NS, Rader JS, Broker TR et al. Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA 2009; 15: 637-647.
15. Muralidhar B, Goldstein LD, Ng G, Winder DM, Palmer RD, Gooding EL et al. Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels. J Pathol 2007; 212: 368-377.
16. Muralidhar B, Winder D, Murray M, Palmer R, Barbosa-Morais N, Saini H et al. Functional evidence that Drosha overexpression in cervical squamous cell carcinoma affects cell phenotype and microRNA profiles. J Pathol 2011; 224: 496-507.
17. Hu X, Schwarz JK, Lewis Jr. JS, Huettner PC, Rader JS, Deasy JO et al. A microRNA expression signature for cervical cancer prognosis. Cancer Res 2010; 70: 1441-1448.
18. Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ, Hwang SY et al. Altered MicroRNA expression in cervical carcinomas. Clin Cancer Res 2008; 14: 2535-2542.
19. Lui WO, Pourmand N, Patterson BK, Fire A. Patterns of known and novel small RNAs in human cervical cancer. Cancer Res 2007; 67: 6031-6043.
20. Rao Q, Zhou H, Peng Y, Li J, Lin Z. Aberrant microRNA expression in human cervical carcinomas. Med Oncol 2011 (doi:10.1007/s12032-011-9830-2
21. Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C et al. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 2008; 3: E2557.
22. Li Y, Wang F, Xu J, Ye F, Shen Y, Zhou J et al. Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. J Pathol 2011; 224: 484-495.
23. Pereira PM, Marques JP, Soares AR, Carreto L, Santos MA. MicroRNA expression variability in human cervical tissues. PLoS One 2010; 5: E11780.
24. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 2004; 101: 2999-3004.
25. Bray I, Bryan K, Prenter S, Buckley PG, Foley NH, Murphy DM et al. Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: Association of miRNA expression with survival. PLoS One 2009; 4: E7850.
26. Lionetti M, Agnelli L, Mosca L, Fabris S, Andronache A, Todoerti K et al. Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles. Genes Chromosomes Cancer 2009; 48: 521-531.
27. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A et al. microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A 2006; 103: 9136-9141.
28. Zhang L, Volinia S, Bonome T, Calin GA, Greshock J, Yang N et al. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci U S A 2008; 105: 7004-7009.
29. Wilting SM, Steenbergen RD, Tijssen M, van Wieringen WN, Helmerhorst TJ, van Kemenade FJ et al. Chromosomal signatures of a subset of high-grade premalignant cervical lesions closely resemble invasive carcinomas. Cancer Res 2009; 69: 647-655.
30. Wilting SM, Snijders PJ, Meijer GA, Ylstra B, van den IJssel PR, Snijders AM et al. Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix. J Pathol 2006; 209: 220-230.
31. Tase T, Okagaki T, Clark BA, Twiggs LB, Ostrow RS, Faras AJ. Human papillomavirus DNA in adenocarcinoma in situ, microinvasive adenocarcinoma of the uterine cervix, and coexisting cervical squamous intraepithelial neoplasia. Int J Gynecol Pathol 1989; 8: 8-17.
32. van Wieringen WN, van de Wiel MA. Nonparametric testing for DNA copy number induced differential mRNA gene expression. Biometrics 2009; 65: 19-29.
33. Mascaux C, Laes JF, Anthoine G, Haller A, Ninane V, Burny A et al. Evolution of microRNA expression during human bronchial squamous carcinogenesis. Eur Respir J 2009; 33: 352-359.
34. Woods K, Thomson JM, Hammond SM. Direct regulation of an oncogenic micro- RNA cluster by E2F transcription factors. J Biol Chem 2007; 282: 2130-2134.
35. Henson BJ, Bhattacharjee S, O0Dee DM, Feingold E, Gollin SM. Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy. Genes Chromosomes Cancer 2009; 48: 569-582.
36. Guo LM, Pu Y, Han Z, Liu T, Li YX, Liu M et al. MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1. FEBS J 2009; 276: 5537-5546.
37. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65: 7065-7070.
38. Hildebrandt MA, Gu J, Lin J, Ye Y, Tan W, Tamboli P et al. Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene 2010; 29: 5724-5728.
39. Lujambio A, Calin GA, Villanueva A, Ropero S, Sanchez-Cespedes M, Blanco D et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A 2008; 105: 13556-13561.
40. Hsu PY, Deatherage DE, Rodriguez BA, Liyanarachchi S, Weng YI, Zuo T et al. Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells. Cancer Res 2009; 69: 5936-5945.
41. Lehmann U, Hasemeier B, Christgen M, Muller M, Romermann D, Langer F et al. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol 2008; 214: 17-24.
42. Weber B, Stresemann C, Brueckner B, Lyko F. Methylation of human microRNA genes in normal and neoplastic cells. Cell Cycle 2007; 6: 1001-1005.
43. Bueno MJ, Perez de CI, Gomez de CM, Santos J, Calin GA, Cigudosa JC et al. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 2008; 13: 496-506.
44. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010; 31: 766-776.
45. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 2008; 68: 2094-2105.
46. Sang CC, Yeung WK, Ying LC, Ping CL, Kwan HP, Yan CS et al. Epigenetic inactivation of the hsa-miR-203 in haematological malignancies. J Cell Mol Med 2011; 15: 2760-2767.
47. Botezatu A, Goia-Rusanu CD, Iancu IV, Huica I, Plesa A, Socolov D et al. Quantitative analysis of the relationship between microRNA124a, -34b and -203 gene methylation and cervical oncogenesis. Mol Med Report 2011; 4: 121-128.
48. Wentzensen N, von Knebel DM. Biomarkers in cervical cancer screening. Dis Markers 2007; 23: 315-330.
49. Jacobs MV, Snijders PJ, van den Brule AJ, Helmerhorst TJ, Meijer CJ, Walboomers JM. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 1997; 35: 791-795.
50. Steenbergen RD, Walboomers JM, Meijer CJ, van der Raaij-Helmer EM, Parker JN, Chow LT et al. Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: Activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q. Oncogene 1996; 13: 1249-1257.
51. Steenbergen RD, Kramer D, Meijer CJ, Walboomers JM, Trott DA, Cuthbert AP et al. Telomerase suppression by chromosome 6 in a human papillomavirus type 16- immortalized keratinocyte cell line and in a cervical cancer cell line. J Natl Cancer Inst 2001; 93: 865-872.
52. Wilting SM, de WJ, Meijer CJ, Berkhof J, Yi Y, van Wieringen WN et al. Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer. Genes Chromosomes Cancer 2008; 47: 890-905.
53. Manduchi E, Grant GR, McKenzie SE, Overton GC, Surrey S, Stoeckert Jr. CJ. Generation of patterns from gene expression data by assigning confidence to differentially expressed genes. Bioinformatics 2000; 16: 685-698.
54. Yi Y, Mirosevich J, Shyr Y, Matusik R, George Jr. AL. Coupled analysis of gene expression and chromosomal location. Genomics 2005; 85: 401-412.
55. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3: 1101-1108.
56. Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 2006; 124: 1169-1181.
57. Overmeer RM, Henken FE, Bierkens M, Wilting SM, Timmerman I, Meijer CJ et al. Repression of MAL tumor suppressor activity by promoter methylation during cervical carcinogenesis. J Pathol 2009; 219: 327-336.
58. Wilting SM, van Boerdonk RA, Henken FE, Meijer CJ, Diosdado B, Meijer GA et al. Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer. Mol Cancer 2010; 9: 167.
59. Steenbergen RD, Kramer D, Braakhuis BJ, Stern PL, Verheijen RH, Meijer CJ et al. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia. J Natl Cancer Inst 2004; 96: 294-305.
60. Steenbergen RD, Parker JN, Isern S, Snijders PJ, Walboomers JM, Meijer CJ et al. Viral E6-E7 transcription in the basal layer of organotypic cultures without apparent p21cip1 protein precedes immortalization of human papillomavirus type 16- and 18-transfected human keratinocytes. J Virol 1998; 72: 749-757.